Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.

Subjects

Subjects :

Alemtuzumab
Anemia, Sickle Cell immunology
Anemia, Sickle Cell pathology
Child
Child, Preschool
Female
Graft Rejection
Graft Survival drug effects
Humans
Infant
Male
Unrelated Donors
Vidarabine therapeutic use
Anemia, Sickle Cell therapy
Antibodies, Monoclonal, Humanized therapeutic use
Busulfan therapeutic use
Cord Blood Stem Cell Transplantation
Myeloablative Agonists therapeutic use
Transplantation Conditioning
Vidarabine analogs & derivatives

Details

Language :

English

ISSN :

1523-6536

Volume :

19

Issue :

4

Database :

MEDLINE

Journal :

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Publication Type :

Report

Accession number :

23403308

Full Text :

https://doi.org/10.1016/j.bbmt.2013.02.002